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Abstract 
This work aims to provide an effective and novel solution for the treatment of infection by using 
nanovehicles loaded with antibiotics capable of penetrating the bacterial wall, thus increasing the 
antimicrobial effectiveness. These nanosystems, named "nanoantibiotics", are composed of 
mesoporous silica nanoparticles (MSNs), which act as nanocarriers of an antimicrobial agent 
(levofloxacin, LEVO) localized inside the mesopores. To provide the nanosystem of bacterial 
membrane interaction capability, a polycationic dendrimer, concretely the poly(propyleneimine) 
dendrimer of third generation (G3), was covalently grafted to the external surface of the LEVO-
loaded MSNs. After physicochemical characterization of this nanoantibiotic, the release kinetics of 
LEVO and the antimicrobial efficacy of each released dosage were evaluated. Besides, 
internalization studies of the MSNs functionalized with the G3 dendrimer were carried out, showing 
a high penetrability throughout Gram-negative bacterial membranes. This work evidences that the 
synergistic combination of polycationic dendrimers as bacterial membrane permeabilization agents 
with LEVO-loaded MSNs triggers an efficient antimicrobial effect on Gram-negative bacterial 
biofilm. These positive results open up very promising expectations for their potential application in 
new infection therapies.  
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1. Introduction 
Over the last few years, the development of antimicrobial resistance and its therapeutic implications 
has become one of the main threats to global health, even talking about the emergence of a new 
"post-antibiotic era" in which antimicrobial treatment will be useless, given the multidrug-resistant 
nature of numerous microorganisms [1]. Although the majority of these microorganisms are Gram-
positive bacteria, infections caused by the Gram-negative microbes currently have rightly drawn 
attention, mainly due to the greater difficulty in dealing with them. This drawback lies basically in 
the presence of an outer membrane that serves as a highly impermeable barrier, as well as additional 
defense mechanisms that might be absent in Gram-positive bacteria [2-4]. Another added 
inconvenience is the formation of structures known as biofilms, which constitute a natural 
mechanism of defense of the microorganisms against external aggressions, including antibiotics, 
reason why their use even hinders the management of these infections [5]. The association of the 
phenomenon of multiresistance with the appearance of biofilm is results in almost intractable 
infections using the currently available antibiotic strategies [6].  
Nowadays, there is an urgent need to combat biofilm-associated infections through the design of 
nanoplatforms able to prevent biofilm formation or to produce dispersion of preformed biofilms 
[7,8]. As well, one of the most important challenges in infection therapy is the design of nanocarriers 
able to selectively transport antimicrobial agents to the target site and, once there, release them in a 
controlled fashion [9-12]. Bacteria-targeted nanoparticles offer promising expectations to improve 
drug efficacy, compliance, and safety [13,14]. Both Gram-positive and Gram-negative bacteria 
possess different components in their outer membranes, which are easily deprotonated to produce 
negative charges, increasing their hydrophilicity [15]. Cationic polymers and moieties have been 
proposed as bacterial detection probes via electrostatic interaction [16] and they have been applied in 
the immobilization and detection of bacteria, mainly owing to the high toxicity of these components 
[15,17,18]. 
Dendrimers are single molecular weight, tree-like globular macromolecules with structural 
uniformity consisting of a central core, branching layers, and numerous end groups [19]. Their 
unique properties make them good nanoplatforms for different areas of biomedicine, used as protein 
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mimics, drug delivery agents, imaging and antiviral and antibacterial agents [9,20,21]. Moreover, it 
has been reported that polycationic dendrimers, exhibiting high concentration of positively charged 
amine groups, are able to efficiently bind to negatively charged bacteria cell walls, increase bacterial 
membrane permeability and internalize inside the bacteria [10,22].  
Regarding inorganic nanomaterials, mesoporous silica nanoparticles (MSNs) are excellent 
candidates to develop targeted drug delivery devices owing to their high biocompatibility, 
intrinsically large drug loading capacity and versatility in terms of chemical modification of its 
surface [23-28]. Herein, a new class of antimicrobial agent, named “nanoantibiotic”, based on MSNs 
functionalized in the external surface with the polypropyleneimine (PPI) dendrimer of third 
generation (G3) has been developed. Since a generation dependent cytotoxicity has been observed 
when dealing with polycationic dendrimers, in this approach we have selected a low non-toxic third 
generation [29]. Moreover, to overcome the drawback of the limited surface charges of low 
generation dendrimers the attachment of several dendritic molecules to the same nanoparticle is 
accomplished [30-32]. The positive charge of this nanosystem behaves as internalization agent able 
to penetrate the negatively charged bacteria wall. The mesoporous structure allows the loading of 
levofloxacin (LEVO) as antimicrobial drug. The synergistic combination of both elements into a 
unique nanosystem produces an efficient antimicrobial effect on bacterial biofilm. The influence of 
the chemical nature of these G3 polycationic dendrimers on the performance of the nanoantibiotic 
has been investigated. For this purpose, this nanosystem was compared with MSNs externally 
functionalized with a model low molecular weight diamine. To date accurately mechanistic studies 
have been reported with star nanoparticles of organic nature (structurally nanoengineered 
antimicrobial peptide polymers), where membrane attachment and internalization in Gram-negative 
bacteria have been demonstrated [13]. However, to the best of our knowledge, this is the first study 
where internalization of inorganic MSNs in Gram-negative bacteria is reported. 
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2. Experimental section 
2.1. Reagents 
All reactions for the synthesis of the silylated dendrimer and for the chemical modification of the 
silica surface were performed under an inert atmosphere by using standard Schlenk techniques. 
Dichloromethane (CH2Cl2, Sigma-Aldrich) was dried by standard procedures over phosphorus (V) 
oxide and distilled immediately prior to use. 
Compound G3-Si(OEt)3 was synthesized following our previous reported procedure [33]. 
Fluorescein isothiocyanate (FITC), tetraethylorthosilicate (TEOS), cetyltrimethylammonium 
bromide (CTAB) and LEVO were purchased from Sigma-Aldrich. 3-Aminopropyltriethoxysilane 
97% (APTS), [3-(2-aminoethylamino)propyl]trimethoxysilane 95% (DAMO) and 3-
isocyanatopropyltriethoxysilane 95% were purchased from ABCR GmbH & Co. KG., and the G3-
PPI dendrimer [G3(NH2)16] from SyMO-Chem. These compounds were used without further 
purification.  
Deionized water was further purified by passage through a Milli-Q Advantage A-10 purification 
system (Millipore Corporation) to a final resistivity of 18.2 MΩ cm. All other chemicals (ammonium 
nitrate, absolute EtOH, dry toluene, NaOH, etc.) were of the highest quality commercially available 
and used as received. 
The following analytical methods were used to characterize the synthesized compounds: solution 
state NMR spectroscopy; high resolution magic angle spinning (HR-MAS) NMR spectroscopy; solid 
state MAS NMR and cross polarization (CP) MAS NMR spectroscopy; Fourier transform infrared 
spectroscopy (FTIR); elemental chemical analyses; thermogravimetric and differential thermal 
analysis (TGA); low-angle powder X-ray diffraction (XRD); N2 adsorption porosimetry; 
electrophoretic mobility measurements to calculate the values of zeta-potential (ζ); dynamic light 
scattering (DLS); scanning electron microscopy (SEM); energy dispersive X-ray spectroscopy 
(EDS); and transmission electron microscopy (TEM). The used equipment and conditions are 
described in the Supporting Information. 
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2.2. Synthetic procedures 
2.2.1 Synthesis of MSN material 
5 µL of APTS (0.023 mmol) was added under stirring and N2 atmosphere to a solution of 2 mg of 
FITC (0.005 mmol) in 0.250 mL of EtOH. After 2 h stirring at RT in the dark, 5 mL of TEOS (22.4 
mmol) was added and the resulting solution was transferred to a syringe dispenser to be used in the 
next reaction. Separately, 1 g of CTAB (2.74 mmol) was dissolved in 480 mL of water and 3.75 mL 
of NaOH 2 M and heated to 80 °C. Then, the solution containing the silylated fluorescein derivative 
and TEOS was added under vigorous stirring at a constant rate of 0.26 mL/min. The vigorous 
stirring and 80 °C were maintained for 2 h and the suspension was cooled to room temperature (RT). 
The solid particles were isolated and washed by centrifuging several times with water and EtOH and 
finally dried. The ion exchange method was employed for the removal of the surfactant using an 
extracting solution of NH4NO3 (10 g/L) in EtOH/H2O (95:5, v/v). A well-dispersed suspension of 1 
g of surfactant-containing MSNs in 350 mL of extracting solution was heated to 80 °C under stirring 
for 2 h and then the solid was thoroughly washed with water and EtOH. This extraction process was 
repeated two or three times and the solid was dried affording MSN material (SBET = 1090 m2/g). 
2.2.2 Synthesis of the silylated dendrimer G3-Si(OEt)3 
Under inert atmosphere, a solution of 3-isocyanotopropyltriethoxysilane (12 µL, 0.018 mmol) in dry 
CH2Cl2 (20 mL) was added dropwise to a vigorous stirred solution of G3-PPI dendrimer (0.078 g, 
0.018 mmol) in dry CH2Cl2 (35 mL). The addition was carried out under an inert atmosphere of N2, 
vigorous stirring and with an addition time of about 2 h. The reaction mixture was stirred overnight 
at RT and the proper progress of reaction was checked by FTIR and 1H NMR spectroscopies. 
Subsequently, the solution was concentrated by partial removal of solvent under reduced pressure in 
the vacuum line and the product was immediately used for the covalent attachment to the silica 
surface. 
2.2.3. Surface functionalization of the MSN materials  
MSN materials were firstly dried under vacuum at 80 °C for 5 h and then re-dispersed in a dry  
  
7 
solvent under N2, by using vortex shaking and ultrasound cycles for nearly 30 min or until an 
adequate suspension was attained. 
MSN-DAMO: A solution of 0.028 g of DAMO (57 µL, 5% excess) in 5 mL of dry toluene was 
added to a vigorously stirred suspension of 0.500 g of the CTAB-containing MSNs (34% wt, i.e., 
0.329 g MSNs) in 100 mL of dry toluene and the mixture was heated to 110 °C overnight. The solid 
was isolated, exhaustively washed with toluene and acetone and then dried under vacuum at 30 °C. 
Finally, the surfactant was removed by ion exchange as above described. 
MSN-G3: For the covalent anchorage of the dendrimers onto the external surface of the MSN 
sample, the freshly obtained solution of silylated G3-PPI dendrimer, G3-Si(EtO)3, was checked 
(FTIR and 1H NMR spectroscopy) and immediately employed in the post-grafting reaction with the 
MSN material. After solvent evaporation from the solution to approximately 10 mL it was added 
dropwise under N2 to a suspension of 0.250 g of MSN in 25 mL of dry CH2Cl2. The mixture was 
stirred overnight, the solid particles isolated and exhaustively washed with CH2Cl2 and dried under 
vacuum at 30 °C. 1H HR MAS NMR δH (500 MHz, D2O): 3.27 (br, CH2NHCONH), 3.20 (br, 
CH2NH2), 2.86 (br, CH2N), 2.07 (br, NH2), 1.92 (br, CH2CH2CH2), 1.81 (br, CH2CH2CH2CH2), 0.87 
(t, CH2Si).  
 
2.3. Drug loading and “in vial” release assays 
2.3.1. Levofloxacin loading into MSN materials 
LEVO loading in the inner pores of MSN materials was performed following an impregnation 
method [34]. MSN and MSN-DAMO materials were loaded by soaking 50 mg of the nanoparticles 
in 10 mL of a LEVO solution in ethanol (5 mg/mL) and the suspension was stirred at RT for 24 h 
preserved from light. Then, the materials were filtered, gently washed with absolute ethanol, dried 
under vacuum and denoted as MSN-L and MSN-DAMO-L samples.  Taking into account the size 
of the third generation dendrimer, the loading process was performed during the same step of 
external functionalization of the MSN material with G3-Si(OEt)3, which is accomplished in dry 
CH2Cl2. In a first assay, MSN material was loaded by soaking 50 mg of the nanoparticles in 10 mL 
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of a LEVO solution in CH2Cl2 (5 mg/mL) and the suspension was stirred at RT for 16 h in dark 
conditions. Then, the sample was filtered, gently washed with CH2Cl2, dried under vacuum and 
characterized to assess the right loading of LEVO using this solvent.  To afford MSN-G3-L, 250 mg 
of vacuum dried MSN were resuspended in 25 mL of a LEVO solution in dry CH2Cl2 (10 mg/mL) 
and stirred at RT for 16 h in darkness conditions. To this suspension a solution of the freshly 
prepared G3-Si(OEt)3 (amounts and conditions as described above for the functionalization of 250 
mg of MSN) was added and stirring was maintained for another 16 h, at RT in the absence of light. 
Then, the sample was filtered, gently washed with CH2Cl2 and dried under vacuum.  The amount of 
drug loaded in MSN materials was determined from the elemental chemical analyses and TGA. 
2.3.2. “In vial” levofloxacin release assays from MSNs 
The kinetic studies of LEVO release were carried out in phosphate buffered saline (PBS) at 37 °C 
and physiological pH of 7.4. A double-chamber cuvette with two different compartments (sample 
and analysis) separated by a dialysis membrane (12 kDa molecular weight cut-off) that only allows 
the LEVO diffusion was employed for the experiments. Briefly, 170 µL of a suspension of the 
loaded MSN material in PBS (8 mg/mL) was placed in the sample compartment and 3.6 mL of fresh 
PBS were located in the analysis one. This system was kept at 37 °C and magnetic stirring was 
applied to the analysis compartment. At every analysis time, the solution in the analysis 
compartment was removed for analysis and replaced by fresh medium. The amount of LEVO 
released was determined by fluorescence spectroscopy using a BiotekPowerwave XS 
spectrofluorimeter, version 1.00.14 of the Gen5 program, with λex = 292 nm and λem = 494 nm. First, 
a calibration curve was established in a concentration range from 0.01 to 12 µg/mL.  
 
2.4. Microbiological assays 
Briefly, bacteria culture was carried out by inoculation in Todd Hewitt broth 
 (THB; Sigma-Aldrich) and incubated overnight at 37 °C with orbital shaking at 200 rpm. After 
culture, bacteria were centrifuged for 10 min at 3,500 g at 22 °C. The supernatant was then discarded 
and the pellet was washed three times with sterile PBS. The bacteria were then suspended and 
diluted in PBS to obtain a concentration of 2 × 108 bacteria per mL. Bacteria concentration was 
  
9 
determined by spectrophotometry using a visible spectrophotometer (Photoanalizer D-105, Dinko 
instruments). Gram-negative bacteria as Escherichia coli (E. coli ATCC25922 laboratory strain) 
were used. 
2.4.1. Antimicrobial effect of levofloxacin dosage from MSNs 
To determine the effectiveness of the LEVO dosages released from the different MSNs against 
bacteria growth, 100 µL of each dosage was inoculated in 900 µL of 108 bacteria per mL in PBS and 
incubated overnight. The presence or not of bacteria, as well as their quantification, was determined 
by counting the colony forming units (CFUs) in agar [35]. In this sense, 10 µL of this solution was 
seeded onto tryptic soy agar (TSA) and incubated at 37 °C overnight and subsequent counting. 
Controls containing bacteria was also performed and the experiments were performed in triplicate. 
2.4.2. Internalization into E. coli bacteria 
Sterilized round cover glasses were coated with poly-D-lysine (0.3 mL per well from a 0.1 mg/mL 
stock solution in Dulbecco’s Phosphate Buffered Saline, PBS, Sigma Aldrich) for 90 min. Then, the 
excess poly-D-lysine was removed by washing with sterilized Milli-Q water (2 × 0.5 mL) and the 
round cover glasses were left to dry overnight in a sterile environment. The poly-D-lysine coated 
round cover glasses were placed in 24 well culture plates (CULTEK). Then, 500 µL of the 2 × 108 
bacteria per mL was added onto the cover glass and subsequently 500 µL of the nanosystems 
suspensions in PBS were inoculated and incubated at 37 °C and 200 rpm in orbital stirring during 90 
min. Different concentration of nanosystems (5, 10 and 20 µg/mL) were studied. Then, the glass 
discs were washed twice with sterile Hank’s balanced salt solution (HBSS, Sigma-Aldrich) and 1 
mL of HBSS was added. To stain the bacteria wall in red, FM 4-64FX dye (0.2 mL from a 5 µg/mL 
stock solution in HBSS, Invitrogen) was added and incubated on ice for 10 min with regular mixing. 
After incubation, the cover glasses were washed with HBSS and fixed with 2% wt/vol 
paraformaldehyde in PBS for 10 min at RT. The fixative was removed with HBSS twice and 0.5 mL 
of HBSS was added to each well before imaging. The samples were examined in an Olympus 
FV1200 confocal microscope. All images are representative of three independent experiments.  
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2.4.3. Antimicrobial effect of MSNs and LEVO-loaded MSNs in planktonic bacteria  
To determine the antimicrobial effect of the different MSNs and LEVO-loaded-MSNs 10 µg/mL of 
each sample was inoculated in 900 µL of 108 bacteria per mL in PBS and incubated during 90, 180 
and 1440 min. For comparison, the antimicrobial effect of free LEVO (1.88 µg/mL) was also 
evaluated. The presence or not of bacteria, as well as their quantification, was determined by CFUs 
in agar. Thus, 10 µL of this solution was seeded onto TSA, incubated at 37 °C overnight and 
subsequently the number of CFUs was counted. Controls containing bacteria was also performed and 
the experiments were performed in triplicate. 
2.4.4. Antimicrobial effects against Gram-negative E. coli biofilm 
Effectiveness of the LEVO loaded nanosystems against biofilm was also determined. For this 
purpose, E. coli biofilms were previously developed onto poly-D-lysine coated round cover glasses 
by suspended the round cover glasses in a bacteria suspension of 108 bacteria per mL during 48 h at 
37 °C and orbital stirring at 100 rpm. In this case, the medium used was 66% THB + 0.2% glucose 
to promote a robust biofilm formation. After that, the round cover glasses containing the biofilm 
were placed onto 24 well culture plates (CULTEK) in 1.5 mL of new medium. Then, 0.5 mL of a 
suspension of MSN materials in PBS at final concentration of 5 and 10 µg/mL was added. After 90 
min of incubation, the glass discs were washed three times with sterile PBS and 3 µL/mL of 
Live/Dead® Bacterial Viability Kit (BacklightTM) was added. Also, 5 µL/mL of calcofluor solution 
was added to stain the mucopolysaccharides of the biofilm (extracellular matrix) in blue to 
specifically determine the biofilm formation. Both reactants were incubated for 15 min at RT. 
Controls containing biofilm bacteria were also performed. Biofilm formation was examined in an 
Olympus FV1200 confocal microscope and eight photographs (60× magnification) were taken of 
each sample [36,37]. The surface area covered with adhered bacteria was calculated using ImageJ 
software (National Institute of Health, Bethesda, MD). All images are representative of three 
independent experiments. 
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2.5. Statistics 
Data are expressed as means ± standard deviations of a representative of three independent 
experiments carried out in triplicate. Statistical analysis was performed using the Statistical Package 
for the Social Sciences (SPSS) version 19 software. Statistical comparisons were made by analysis 
of variance (ANOVA). Scheffé test was used for post hoc evaluations of differences among groups. 
In all of the statistical evaluations, p˂0.05 was considered as statistically significant. 
 
3. Results and Discussion 
3.1. MSN material synthesis 
Fluorescent MSNs were synthetized by covalently linking the fluorescent dye to the silica network 
following a modified Stöber method [38-40]. SEM analysis of the obtained MSNs revealed a 
uniform spherical morphology with an average particle diameter of ca. 150 nm (Fig.S1 in 
Supporting Information). Low-angle XRD measurement showed a well-resolved pattern of 2D 
hexagonal MCM-41 materials, with a unit cell parameter of 4.55 nm. The well-ordered mesoporous 
structure was also confirmed by N2 adsorption porosimetry, possessing an average pore diameter of 
2.4 nm and 1090 m2/g of surface area. 
 
3.2. External functionalization of the MSN material 
The functionalization of MSN materials was intended only in the outer surface of the nanoparticles 
to keep free the inner mesoporous surface (Fig.1). The post-synthetic method via condensation of 
alkoxysilane derivatives with silanol groups of the silica surface, under water-free conditions, was 
used to covalently attach the amine moieties to the silica support [41]. The amount of the 
alkoxysilane was established from the surface area (SBET) of the MSNs, of which the 25% was taken 
into account for the external surface, with an average surface concentration of Si-OH groups of 4.9 
OH/nm2 [42]. A molar ratio of three Si-OH groups with one R-Si(OEt)3 moiety was considered as 
the stoichiometry of the condensation reaction. 
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To graft DAMO moieties to the outer surface of the MSNs (MSN-DAMO), the as-synthesized 
material containing the organic template filling the pores was used in the condensation reaction and 
its removal was performed afterwards [43]. By using this approach, a preferential functionalization 
of the external surface of MSNs is expected [43]. A 100% nominal degree of the external surface 
functionalization was considered to attain a maximum coverage. 
However, for the preparation of the MSN-G3 material, we kept in mind the possibility that the size 
of third generation dendrimers would prevent the functionalization of the interior of the MCM-41 
pores [40]. In addition, the expected steric hindrance between third generation dendrimers at the 
silica surface prevents from a total silanol functionalization [33]. Thus, for the preparation of the 
MSN-G3 material, we calculated the amount of dendrimer required to functionalize a quarter of the 
external surface of the MSNs. 
 
3.3. Materials characterization 
The organic content of the MSN materials was quantified from TGA and elemental chemical 
analyses to follow the incorporation of the alkoxysilane derivatives (Table 1). The results confirm 
the expected increase of the organic content after functionalization of the MSNs, although the MSN-
DAMO material possesses a higher organic content compared to the dendritic functionalized MSN-
G3. This fact reflects the steric hindrance that occurs when macromolecules are employed to 
functionalize the silica surface, resulting in a more effective incorporation of the smaller 
alkoxysilane. Therefore, in terms of functionalization degree (calculated in mmol per gram of 
material) the MNS-DAMO material incorporates almost 18 times more alkoxysilane reactive groups 
than MSN-G3. 
Changes in the ζ-potential values of the different nanoparticles were also used to assess the 
functionalization process. Incorporation of DAMO, as well as incorporation of the G3 dendrimer, 
produces a drastic change on the MSN material from negative to positive ζ-potential values. As 
shown in Table 1, values change from −36.4 mV in bare MSN to ca. +35 mV in the hybrid 
materials. Both functionalized materials possess amine groups susceptible to protonation; however, 
the incorporation of the polycationic dendrimer does not exceed the positive value reached with the 
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DAMO molecule. The possible acid-base equilibriums of the different functional groups over the 
nanoparticle silica surface in water and their corresponding pKa values, considering the acid-base 
properties of the different functional groups, are the following: deprotonation of the silanol groups in 
all MSN materials, the bare and the amino functionalized hybrid materials [Eq. (1)],  protonation of 
the primary and secondary amine groups in DAMO [Eq. (2) and (3)] and protonation of the primary 
and tertiary amine groups in G3 dendrimer [Eq. (4) and (5)] [44-46]. 
R-Si-OH  +  H2O  ↔  R-SiO−  +  H3O+  pKa ≈ 6.8   Eq. (1) 
R-NH2  +  H2O  ↔  R-NH3+  +  OH−  pKa ≈ 10.4  Eq. (2) 
R2-NH  +  H2O  ↔  R2-NH2+  +  OH−  pKa ≈ 9.2  Eq. (3) 
R-NH2  +  H2O  ↔  R-NH3+  +  OH−  pKa ≈ 9.8  Eq. (4) 
R3-N  +  H2O  ↔  R3-NH+  +  OH−  pKa ≈ 6.1  Eq. (5) 
Therefore, two main factors can be considered to explain a more positive value for the MSN-DAMO 
material: First, it is reflected the greater degree of functionalization achieved with the smaller 
molecule (see F value in Table 1). In MSN-DAMO most of the silanol groups (-Si-OH) over the 
nanoparticle surface have reacted during the functionalization, therefore not contributing to the -Si-
O− formation in water (see also 29Si MAS NMR discussion below). On the other hand, the pKa 
values of amine moieties in G3 are slightly lower than pKa values of amines in DAMO, mainly due 
to a polyelectrolyte behavior in the macromolecule that reflects the effect of electrostatic repulsion 
between different charged sites. This effect entails the decrease of the pKa value with the increase of 
the protonation degree. Therefore, under the same conditions in the water media protonation would 
be more favorable for MSN-DAMO than for MSN-G3 material. The same behavior was found in 
PBS medium; however, ζ-potential values measured in THB were found to be negative for bare 
MSN as well as both functionalized MSN-DAMO and MSN-G3 materials, probably reflecting the 
adsorption of a protein corona on the surface of the nanoparticles [47]. 
The hydrodynamic particle diameter (DH) of the nanoparticles was determined by DLS in water, 
PBS and THB media and the obtained values are shown in Table 1. The materials suspended in 
water display a hydrodynamic size distribution comprised between 140-190 nm, which indicates that 
the grafting process does not significantly alter the nanoparticle size. Nonetheless, the functionalized 
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MSNs possess a smaller hydrodynamic size, reflecting a decrease in the magnitude of the aggregates 
of nanoparticles in water media. All MSNs exhibit high enough ζ-potential values, either negative or 
positive, to be in the colloidal stability zone [48], but the presence of organic molecules attached to 
the external surface of the MSNs in the hybrid materials contributes as well to a steric repulsion that 
decreases the size of the aggregates in solution. In PBS and THB media the hydrodynamic size for 
all the materials increases slightly, being the maximum registered values 234 nm for MSN sample in 
THB and 263 nm for MSN-G3 sample in PBS. This slight increase in the hydrodynamic size for all 
materials in PBS and THB with respect to water may be a reflection of the shift in the ζ-potential 
toward values somewhat further away from the colloidal stability zone. However, DH values for all 
materials in the different media are in a range where large aggregates can be discarded. 
Fig. 2A shows the 1H high-resolution magic angle spinning (HRMAS) NMR spectrum of the MSN-
G3 material. The chemical shifts closely match those of the respective functional groups in the 
solution NMR spectrum of the free G3 dendrimer, supporting the presence of this compound on the 
surface of the nanoparticles [33]. 
The presence of the G3 dendrimer on the surface of the nanoparticles is supported by the chemical 
shifts of the hybrid material, which closely match those of the respective functional groups in the 
solution NMR spectrum of the free compound [33]. The broadening of the signals with respect to the 
solution NMR spectrum is a normal fact due to the immovilization of the organic matter onto the 
solid nanoparticles. A sligth downfield shift of the signals can be adscribed to the use of different 
deuterated solvents as well as techniques and equipments [44,49]. 
Fig. 2B shows the 13C{1H} CP MAS NMR spectrum of the MSNs-DAMO material including the 
chemical shifts and their assignments. The observed 13C chemical shifts correspond to the DAMO 
molecule proving its presence in the nanoparticles. 
A common fact for MSN-G3 and MNS-DAMO materials is that signals due to ethoxy groups show 
up in both 1H and 13C MAS NMR spectra, respectively. These signals are also present in the 13C 
MAS NMR of the bare MSN sample. Furthermore, if we take into account that a 7.8% of organic 
content was found by TG analysis for the bare MSNs, the explanation for this signals is that they 
come from ethoxy groups from incomplete hydrolysis and condensation of the TEOS precursor 
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during the sol-gel synthesis of MSNs. Then, the extraction method used to remove the CTAB 
surfactant leaves intact these groups in the silica network, unlike a calcination process would do. 
Further analysis of the functionalization of the MSNs was performed by 29Si MAS NMR 
spectroscopy (Fig. 2C). The chemical shifts at around δ = −94, −102 and −112 ppm apperar in all the 
spectra and represent the Q2 [Si(OSi)2(OX)2], Q3 [Si(OSi)3(OX)] and Q4 [Si(OSi)4] silicon sites, 
respectively (X = H, C). Table 2 displays the populations of these silicon environments. The 
conversion of Si-OH groups to fully condensed Si-O-Si species during the post-grafting reaction is 
reflected in a decrease on the Q2 and Q3 peak areas and an increase in the Q4 peak area, i.e., a 
decrease in the (Q2 + Q3)/Q4 ratio. This fact confirms the existence of covalent linkages between the 
silica surface and the organic groups in the MSN-DAMO and MSN-G3 materials. Signals for T2 [R-
Si(OSi)2(OX)] and T3 [R-Si(OSi)3] silicon sites appear at around δ = −58 and −68 ppm, respectively, 
in the MSN-DAMO spectra. However, signals for the T groups in the spectra of the MSN-G3 
material are absent due to the low proportion of this silicon environment in the silylated G3 
dendrimer. 
The remaining populations of Q2 and Q3 sites after functionalization, for both MSN-DAMO and 
MSN-G3 hybrid materials, indicates that the inner surface of the channels was preserved from 
functionalization. In the case of MSN-DAMO, this circumstance is due because the alkoxysilane 
grafting was done in advance to the surfactant extraction. In the case of MSN-G3, the fact is 
adscribed to the bulky size of G3 dendrimers that leads to the attachment of the macromolecules 
onto the external surface of the MSNs. These findings are also verified by the N2 sorption studies 
detailed below (vide infra). The lower decrease in the (Q2+Q3)/Q4 ratio for the MSN-G3 sample also 
points to a lower coverage of the silica surface due to steric hindrance between third generation 
dendrimers. 
Concerning the structural characterization of MSNs before and after functionalization, XRD 
confirms the 2D hexagonal mesoporous arrangement, showing three well-defined reflections that can 
be indexed as 10, 11 and 20 of a p6mm plain group for all the materials (Fig. 3A). These results 
agree with TEM studies (Fig. 3B-D), which show spherical shaped nanoparticles with an average 
diameter of ca. 120 nm. Regarding the mesoporous structure, TEM images evidence the presence of 
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a honeycomb-like mesoporous arrangement typical of MCM-41 structure. These results reveal that 
neither the morphology nor the mesoporous order are affected by the used functionalization 
procedures. 
Fig. 3E shows the N2 adsorption isotherms corresponding to pristine MSN, MSN-DAMO and 
MSN-G3 materials, respectively. All isotherms are IV type according to the IUPAC classification, 
which are characteristic of mesoporous materials exhibiting parallel cylindrical pores [50]. The 
appropriated treatment of the N2 adsorption-desorption data allows to determine the main textural 
parameters (Table 3). Concerning the SBET, it experiences a decrease in both functionalized samples 
compared to pristine MSN, because of the post-grafting of organic moieties [51]. However, the pore 
volume (VP) remains unaltered in MSN-G3 because, in good agreement with NMR results, due to 
the high volume of G3 this macromolecule is not able to functionalize the inner mesoporous cavities 
[33]. However, VP undergoes a remarkable drop in MSN-DAMO. This fact could be ascribed to the 
smaller size of DAMO, which may partially block the pore entrances. These findings are in good 
agreement with the calculated pore diameter (DP) and wall thickness (twall) values, which remain 
constant in MSN-G3 and experience a significant variation (DP decrease and twall increase) in MSN-
DAMO, compared to unmodified MSN material. 
 
3.4. “In vial” levofloxacin release performance 
LEVO was loaded into the different materials by forming well-dispersed suspensions of 
nanoparticles in a solution of LEVO in ethanol or CH2Cl2, i.e., following an impregnation method 
(for further details see Experimental Section) [34]. The amount of LEVO loaded into the samples 
was 3.2%, 5.0% and 7.8% (wt.) for MSN-L, MSN-DAMO-L, MSN-G3-L, respectively. The 
effective drug loading was also evaluated by the reduction in the VP and pore diameter measured by 
N2 adsorption (see Table S1 in Supporting Information). As above explained, the G3 macromolecule 
is not able to functionalize the inner mesoporous cavities and therefore the VP remains almost 
unaltered in MSN-G3 compared to pristine MSN, being available more pore volume accessible for 
drug loading than in MSN-DAMO. In addition, the impregnation method followed for LEVO 
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loading in MSN-G3 is performed before the anchorage of the alkoxysilane on the external surface so 
the accessibility of LEVO to the inner pores is not impeded. 
To assess the performance of the diverse nanosystems, namely MSN-L, MSN-DAMO-L and MSN-
G3-L, under physiological relevant conditions (PBS 1x, pH = 7.4), LEVO release experiments were 
performed “in vial”. Fig. 4A shows the LEVO release profiles from the different matrices after 14 
days. Release profiles can be adjusted to first-order kinetic model by introducing an empirical non-
ideality factor (δ) to give the equation [52]: 
	 = 	1 − 	
        Eq. (6) 
being Y the percentage of LEVO released at time t, A the maximum amount of drug released, and k, 
the release rate constant. In this approach, the values for δ are comprised between 1 for materials 
that obeys fist-order kinetics, and 0, for materials that release the loaded drug in the very initial time 
of test.  
The parameters of the kinetics fitting are also shown in Fig. 4A indicate that the fastest LEVO 
release occurs from MSN-G3 matrix (k = 0.239 h-1), exhibiting a δ = 1, which indicates a first-order 
release kinetics, and releasing 100% of loaded LEVO after 72 h of assay. In the case of MSN-
DAMO and MSN there is a slight variation from the ideal first-order kinetics, with comparable δ 
values in the 0.6-0.7 range. In this case, release rate of MSN-DAMO is faster than that of MSN, 
with k values of 0.051 h−1 and 0.021 h−1, respectively. Previous studies have revealed that there is a 
strong interaction between the LEVO molecules and silica network in MSNs via hydrogen bonding 
between zwitterionic form of this quinolone antibiotic at pH 7.4 and –Si-OH groups of silica 
nanoparticles [34,53]. Thus, pristine MSN sample partially retains the loaded LEVO, releasing less 
than 50% after 14 days of test. On the contrary, the presence of protonated amino groups on the 
external surface of both MSN-DAMO and MSN-G3 samples promotes the interaction with LEVO 
molecules, which provokes drug departure from the mesopores resulting in a faster antibiotic release. 
Fig. 4B displays the LEVO dosages from different samples in the initial stages of the “in vial” 
assays, evidencing the significant highest antibiotic release from MSN-G3, which is 10-fold the 
minimum inhibitory concentration (MIC) for E. coli [54]. Likewise, the LEVO dosages released 
from MSN-DAMO are also significantly above the MIC, being the pristine MSN sample that 
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exhibiting the lowest drug dosages albeit also above the MIC. The in vitro antimicrobial tests of 
these dosages vs Gram-negative E. coli reveal that they are effective for MSN-G3 and MSN-DAMO 
after 1 and 3 h, observing bacterial growth for pristine MSN.  
 
3.5. Evaluation of bacterial internalization 
To directly observing the internalization capability on bacteria cells confocal microscope studies 
were conducted. Fig. 5 displays the confocal images of E. coli (labelled red with lipid membrane 
FM4-64FX) incubated during 90 min with pristine MSN, MSN-DAMO and MSN-G3 (whose silica 
networks were labeled in green with fluorescein). Zoom of the confocal images at 60x of 
magnification clearly evidence notables different among all samples. All images show the bacillus 
morphology of E. coli with the bacterial wall labeled in red, in good agreement with the control. In 
the case of pristine MSN, green scattered dots not close to the bacteria walls are observed, which can 
be attributed to aggregates of nanoparticles not removed during the washing procedure and do not 
interacting with the bacteria wall. On the contrary, MSN-DAMO images display small domains of 
green aggregates corresponding to nanoparticles in the proximity of the bacterial wall obeying 
certain interactions between positive charges of amine groups and the negative bacterial wall. 
Nonetheless, a complete internalization and uniform localization of MSN-G3 nanoparticles 
throughout the cytosol of the bacteria cells is appreciated. These results have been also observed for 
lower concentrations of MSNs of 5 µg/mL (see Fig. S2A in Supporting Information). As bacteria are 
negatively charged and both, MSN-DAMO and MSN-G3 nanoparticles have positive charge 
density, electrostatic interactions bring them into contact with each other. Difference in the 
successful internalization of both hybrid materials may be attributed to the G3 dendritic skeleton, 
which provides MSN-G3 of high surface flexibility. Consequently, there are more interaction points 
in the positively charged amine functional groups of MSN-G3 that are exposed to the negatively 
charged bacterial wall [10]. Therefore, MSN-G3 not only binds to the negatively charged 
phospholipid membranes, but also provokes a slight change in membrane permeability, which finally 
leads to nanosystem internalization into the bacteria, as it has been reported elsewhere for other 
systems [13,55]. Further studies to analyze the effect of MSN-G3 internalization in the bacteria at 
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longer times, as well as to elucidate the interaction and internalization between the nanosystem here 
proposed and bacteria cell membrane are being conducted for a better understanding of the 
mechanism against Gram-negative bacteria. Moreover, to evaluate the potential antimicrobial effect 
of the different samples (MSN, MSN-DAMO and MSN-G3), preliminary studies were carried out 
by incubation of 10µg/mL of each material in 108 bacteria/mL suspensions during 90, 180 and 1440 
min, followed by plating and counting of CFUs (Fig. S3A in Supporting Information). The obtained 
results reveal no significant antimicrobial effect for all materials after 90 min of assay, in good 
agreement with confocal microscopy images (Fig. 5). However, after 180 min of assay there is a 
significant antimicrobial effect in MSN-DAMO and MSN-G3 compared to the control. Finally, 
after 24 h of incubation, the highest antimicrobial effect corresponds to MSN-G3, being 
significantly higher than the control and the other tested samples, reducing ca. 99% the number of 
CFUs. In addition, to further investigating the effect of the incorporation of LEVO into the different 
MSNs in comparison to free LEVO, complementary antimicrobial assays were also performed. The 
results displayed in Fig. S3B (in Supporting Information) indicate that in all cases the presence of 
LEVO leads to a noticeable decrease in the number of CFUs and that this effect is more remarkable 
with the increase of the incubation time.  
 
3.6. In vitro antimicrobial efficacy against E. coli biofilms 
After evaluating the internalization effectiveness and antibiotic release profiles, in vitro 
antimicrobial assays can be performed to assess the efficacy of these nanosystems against E. coli 
biofilms. Fig. 6 shows the most representative results derived from the effects of MSN-L, MSN-
DAMO-L and MSN-G3-L suspensions onto the preformed E. coli biofilm by confocal microscopy. 
Initially, the preformed biofilm displays a typical structure composed of colony live bacteria (green) 
covered by a protective mucopolysaccharide matrix (blue). After 90 min of incubation with the 
different nanoparticles, remarkable differences are detected. MSN-L sample is not able to destroy 
the biofilm, appearing live bacteria colonies coated with its protective layer. However, small 
amounts of scattered dead bacteria are present onto the outermost surface probably due to the action 
of the LEVO released from this material, in agreement with Fig. 4. On the other hand, MSN-DAMO 
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triggers the biofilm disruption, with the presence of small unfilled domains within the colony, 
showing vastly live cells (green), dispersed mucopolysaccharide (blue) fragments and scarcely dead 
cells (red). Finally, the best results are derived from MSN-G3-L assays, which is able to totally 
destroy the biofilm since no blue staining and almost negligible live cells are observed. It should be 
mentioned that even at nanoparticles concentrations of 5 µg/mL the biofilm is destroyed, existing 
dead bacteria (red) covering almost the entire biofilm surface (Fig. S2B in Supporting Information). 
This finding agrees with the synergistic combination of the bacterial penetration capability of 
polycationic dendrimers present in MSN-G3 (Fig. 5) and the antimicrobial effect of LEVO released 
from this matrix (Fig. 4).  
In addition, control experiments with G3 dendrimer, LEVO and a combination G3 and LEVO were 
carried out (Fig. S4 in Supporting Information). The concentration of each compound was that 
corresponding to the G3 grafted to MSNs (MSN-G3) and to the amount of LEVO released from 
MSN-G3-L after 90 min during the “in vial” assay. The results evidence not significant 
antimicrobial effect in any of the cases with respect to the control.  
 
4. Conclusions 
A new class of antimicrobial agent, named “nanoantibiotic”, based on mesoporous silica 
nanoparticles (MSNs) decorated with polypropyleneimine dendrimers of third generation (G3) and 
loaded with levofloxacin (LEVO) as antibiotic has been developed. The covalently grafting of these 
G3 dendrimers to MSNs (MSN-G3) allows an effective internalization in Gram-negative bacteria. 
This internalization can be ascribed to the high density of positive charges and flexibility on the 
surface of the MSN-G3, which produces electrostatic interactions with the negatively-charged 
bacteria walls and triggers their permeabilization. Furthermore, the LEVO antibiotic loaded into the 
mesoporous cavities is released in a sustained manner at effective antimicrobial dosages. These 
findings demonstrate that the synergistic combination of bacterial internalization and antimicrobial 
agents into a unique nanosystem provokes a remarkable antimicrobial effect against bacterial 
biofilm. This novel nanoantibiotic is envisioned as a promising alternative to the current available 
treatments for the management of infection. 
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Appendix A. Supplementary data 
Supplementary data associated with this article can be found in the online version. 
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Table 1 Characteristics of the different MSNs synthesized in this work obtained by elemental 
chemical and TG analyses, ζ-potential and DLS. 
Sample Org. cont. 
(%wt) 
F 
(mmol/g) 
ζ-potencial (mV) DH (nm) 
H2O PBS THB H2O PBS THB 
MSN 7.8 --- -36.4 -23.8 -10.9 190 217 234 
MSN-DAMO 28.6 1.86 37.4 39.3 -15.4 141 158 200 
MSN-G3 19.7 0.106 31.8 17.3 -20.2 142 263 221 
The organic content is determined from the TGA weight losses, excluding the weight loss due 
to the desorption of water (up to 150 °C) and further corrected by the weight loss of the 
surfactant extracted unmodified fluorescent MSNs. The functionalization degree in mmol per 
gram of material (F) was determined from the %N obtained by elemental chemical analyses and 
TG analyses. The ζ-potential values and the DH (by DLS) of nanoparticles were measured in 
different media: Milli-Q water, PBS and THB. 
 
 
 
Table 2 Peak area (%) of the silicon Qn units on the basis of deconvolution of 29Si MAS NMR 
spectra of the different MSNs prepared in this work. 
Sample Q2 Q3 Q4 (Q2+Q3)/Q4 
MSN 9 38 53 0.89 
MSN-DAMO 7 25 70 0.46 
MSN-G3 9 33 58 0.76 
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Table 3 Characteristics of the different MSNs synthesized in this work obtained by XRD and 
N2 adsorption porosimetry. 
Sample a0 
(nm) 
SBET 
(m2/g) 
VP 
(cm3/g) 
DP 
(nm) 
twall 
(nm) 
MSN 4.55 1090 0.85 2.4 2.1 
MSN-DAMO 4.68 670 0.40 2.1 2.5 
MSN-G3 4.35 578 0.90 2.4 2.0 
 
a0 is the unit cell parameter calculated by XRD, being a0 =2.√3 d10. SBET is the surface area 
determined by using the BET method; VP is the total pore volume obtained using the t-plot 
method. The total pore volume was estimated from the amount of N2 adsorbed at a relative 
pressure of 0.97. DP is the pore diameter calculated by means of the BJH method from the 
adsorption branch of the isotherm. twall is the wall thickness calculated using the equation twall = 
a0 − DP. 
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STATEMENT OF SIGNIFICANCE 
Seeking new alternatives to current available treatments of bacterial infections represents a great 
challenge in nanomedicine. This work reports the design and optimization of a new class of 
antimicrobial agent, named “nanoantibiotic”, based on mesoporous silica nanoparticles (MSNs) 
decorated with polypropyleneimine dendrimers of third generation (G3) and loaded with 
levofloxacin (LEVO) antibiotic. The covalently grafting of these G3 dendrimers to MSNs allows an 
effective internalization in Gram-negative bacteria. Furthermore, the LEVO loaded into the 
mesoporous cavities is released in a sustained manner at effective antimicrobial dosages. The 
novelty and originality of this manuscript relies on proving that the synergistic combination of 
bacteria-targeting and antimicrobial agents into a unique nanosystem provokes a remarkable 
antimicrobial effect against bacterial biofilm.  
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